Hydrochloric Acid

Hydrochloric Acid

SCHEMBL714720

Cc1cc2c(C(C)C)ccccc-2c1[Ti+2](c1c(C)cc2c(C(C)C)ccccc1-2)=[Si](C)C.[Cl-].[Cl-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.38
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
TRPA1 O75762 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
PIP4K2C Q8TBX8 1/20 0.32
USP1 O94782 3/20 0.31
WDR48 Q8TAF3 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL713862 0.78 ESR2 (0.36) CA12CA1CA2CA9
SCHEMBL167078 0.71 GABRA1 (0.55) DHFRCA12CA1CA2CA9
SCHEMBL29414063 0.71 GABRA1 (0.55) DHFRCA12CA1CA2CA9
SCHEMBL6314140 0.69 DHFR (0.45) DHFRCA12CA1CA2CA9
Hydrochloric Acid SCHEMBL714723 0.69 DHFR (0.38) DHFRCA12CA1CA2CA9
SCHEMBL9174922 0.69 GABRA1 (0.52) DHFRCA12CA1CA2CA9
Hydrogen Peroxide SCHEMBL9644435 0.67 GABRA1 (0.56) DHFRCA12CA1CA2CA9
SCHEMBL8680514 0.64 GABRA1 (0.44) DHFRCA12CA1CA2CA9
SCHEMBL10457926 0.64 DHFR (0.44) DHFRCA12CA1CA2CA9
SCHEMBL13232504 0.64 CYP2A6 (0.53) DHFRCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357765-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-22 US disclosed
US-8288490-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-16 US disclosed
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed
US-20120053311-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION PPOX, SOD1, AP1M1 DHFR 1105/4885CA12 481/4885CA1 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.